| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |